Autopsy report · NCT00621413

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

“Study never moved forward due to no accrual”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

IsoRay Medical, Inc.

Sponsor type

Industry

Conditions

Prostate Cancer

Participants

0

Sites

9

Countries

United States

Trials that died the same way

• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (86% match in meaning)
• Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
  “Study was halted for lack of accrual” (80% match in meaning)
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  “Study stopped due to low accrual.” (79% match in meaning)
• The Impact of E-liquid Nicotine Content on Reinforcement in Current Smokers
  “Study team decided not to move forward with study” (78% match in meaning)
• Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
  “Accrual was insufficient to meet study endpoints” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.